Clinical Trial Update: ALI Post Radiation Therapy in Patients With Lung and Esophageal Canter [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating ALI after radiation therapy in patients with lung cancer and esophageal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Lung Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Solid Tumor Malignancies | Phase 2 | Status: TERMINATED